ECG
RETA

Edge Capital Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Edge Capital Group’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-25,788
Closed -$2.2M – 262
2019
Q1 		$2.2M Buy
+25,788
New +$2.2M 0.22% 85